Week in Review
HHS proposes rule to strengthen LGBTQ+ protections under ACA, Education Department proposes accountability measures for for-profit colleges, and more . . .
Cancer Moonshot Lands with FDA
FDA releases new guidelines for cancer clinical trials in response to President Biden’s anti-cancer initiative.
With Proposed Menthol Cigarette Rule, FDA Says Cool It
FDA issues proposed rule that would ban menthol as a flavor additive in cigarettes.
The No Surprises Act Still Surprises Consumers
Medical bills may continue to take consumers by surprise despite the No Surprises Act.
Do Not Blame Us
Court disregards the Clean Air Act’s clear language in applying the major questions doctrine to curb EPA’s climate authority.
Making Regulations on Influencer Advertising Click
Scholars offer approaches to improve regulation of social media marketing.
Week in Review
President Biden takes executive climate actions, the House passes bills to protect reproductive and marriage rights, and more…
Legislators as Defendants but Not as Plaintiffs
The Supreme Court increased potential intervening defendants when it implicitly protected voter ID laws.
Supreme Court Crushes the United States’ Ability to Mitigate Climate Change
Rejecting EPA’s ability to reshape the coal industry, the Court forecasts invalidating future agency actions.
Nostalgia for Agency Expertise
Calls for more deference to agency expertise derive from an unrealistic view of executive policymaking.
A Review of Health Care in the Court
Several U.S. Supreme Court cases from this past term have significant implications for the provision of medical care.
Emergency Use or Overuse?
Experts discuss FDA’s COVID-19 emergency authorizations and how to recalibrate the regulatory mechanism.